TWI369362B - Recombinant production of heparin binding proteins - Google Patents

Recombinant production of heparin binding proteins

Info

Publication number
TWI369362B
TWI369362B TW095148610A TW95148610A TWI369362B TW I369362 B TWI369362 B TW I369362B TW 095148610 A TW095148610 A TW 095148610A TW 95148610 A TW95148610 A TW 95148610A TW I369362 B TWI369362 B TW I369362B
Authority
TW
Taiwan
Prior art keywords
binding proteins
recombinant production
heparin binding
heparin
recombinant
Prior art date
Application number
TW095148610A
Other languages
English (en)
Other versions
TW200734351A (en
Inventor
Michelle D Butler
Jeffrey L Cleland
David W Kahn
Shelly Pizarro
Charles H Schmelzer
Marjorie E Winkler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of TW200734351A publication Critical patent/TW200734351A/zh
Application granted granted Critical
Publication of TWI369362B publication Critical patent/TWI369362B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW095148610A 2005-12-22 2006-12-22 Recombinant production of heparin binding proteins TWI369362B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75361505P 2005-12-22 2005-12-22
US80743206P 2006-07-14 2006-07-14
US11/613,012 US20080032343A1 (en) 2005-12-22 2006-12-19 Recombinant Production of Heparin Binding Proteins
PCT/US2006/062320 WO2007130154A2 (en) 2005-12-22 2006-12-19 Recombinant production of heparin binding proteins
ARP060105732A AR058625A1 (es) 2005-12-22 2006-12-21 Produccion recombinante de proteinas de union a heparina

Publications (2)

Publication Number Publication Date
TW200734351A TW200734351A (en) 2007-09-16
TWI369362B true TWI369362B (en) 2012-08-01

Family

ID=38668202

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095148610A TWI369362B (en) 2005-12-22 2006-12-22 Recombinant production of heparin binding proteins

Country Status (17)

Country Link
US (3) US20080032343A1 (zh)
EP (2) EP2336164A1 (zh)
JP (2) JP5036727B2 (zh)
KR (1) KR101067525B1 (zh)
AR (1) AR058625A1 (zh)
AT (1) ATE497973T1 (zh)
AU (1) AU2006343279B2 (zh)
BR (1) BRPI0621124A2 (zh)
CA (1) CA2633554C (zh)
DE (1) DE602007012412D1 (zh)
HK (1) HK1119188A1 (zh)
IL (1) IL191968A (zh)
MY (1) MY143274A (zh)
NZ (1) NZ568809A (zh)
RU (1) RU2385877C1 (zh)
TW (1) TWI369362B (zh)
WO (1) WO2007130154A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9909326B2 (en) 2010-02-25 2018-03-06 John Clement Preston Scaffolding

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
TWI476207B (zh) 2006-07-14 2015-03-11 Genentech Inc 重組蛋白之再摺疊
DK2350271T3 (en) 2008-11-20 2016-04-04 Biogen Ma Inc ARGININ INACTIVATION OF ENVIRONMENT VIRA
EP3366692A1 (en) 2009-06-22 2018-08-29 Amgen, Inc Refolding proteins using a chemically controlled redox state
EP2445924B2 (en) 2009-06-25 2023-12-13 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
KR102283127B1 (ko) * 2018-06-19 2021-07-29 주식회사 엠디헬스케어 류코노스톡속 균주를 포함하는 간 기능 개선용 조성물

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169950A (en) * 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0052322B1 (de) 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4673641A (en) 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4710473A (en) 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
ATE59966T1 (de) 1983-09-26 1991-02-15 Ehrenfeld Udo Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
US4615885A (en) 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
US4795706A (en) 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
ES8800957A1 (es) 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
AU614137B2 (en) 1988-06-06 1991-08-22 Takeda Chemical Industries Ltd. Stabilized fgf composition and production thereof
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5342763A (en) 1992-11-23 1994-08-30 Genentech, Inc. Method for producing polypeptide via bacterial fermentation
EP1013270A3 (en) 1992-12-02 2001-03-28 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5331095A (en) 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP4098372B2 (ja) * 1993-07-28 2008-06-11 三菱化学株式会社 ヘパリン結合性増殖因子の生産方法
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
ES2249762T3 (es) * 1994-03-08 2006-04-01 Human Genome Sciences, Inc. Factor de crecimiento del endotelio vascular 2.
EP0779806B2 (en) 1994-09-09 2008-04-16 Takeda Pharmaceutical Company Limited Sustained release preparation containing metal salt of a peptide
FR2729972B1 (fr) * 1995-01-31 1997-04-18 Sanofi Sa Procede d'extraction de proteines periplasmiques de microorganismes procaryotes en presence d'arginine
DK0831787T3 (da) 1995-06-07 2001-12-17 Alkermes Inc Sammensætning til vedvarende frigivelse af humant væksthormon
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US6632425B1 (en) * 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
US6653098B1 (en) 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
DK1066328T3 (da) 1998-03-31 2009-02-09 Tonghua Gantech Biotechnology Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
PT1084136E (pt) 1998-06-01 2004-12-31 Genentech Inc Separacao de monomeros de anticorpos dos seus multimeros atraves da utilizacao de cromatografia de troca ionica
ES2207340T3 (es) 1998-10-28 2004-05-16 Genentech, Inc. Procedimiento para la recuperacion de polipeptidos heterologos a partir de celulas bacterianas.
US6783953B1 (en) * 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AU5026100A (en) * 1999-05-20 2000-12-12 Scios Inc. Vascular endothelial growth factor dimers
JP3929777B2 (ja) 2000-01-25 2007-06-13 オクラホマ メディカル リサーチ ファウンデーション 組換えタンパク質をリフォールディングするための凡用的な手順
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
EP1273655A4 (en) * 2000-03-30 2004-08-04 Takeda Chemical Industries Ltd METHOD FOR PRODUCING A RECOMBINANT PROTEIN
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
US7611711B2 (en) * 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
EE200300408A (et) 2001-02-23 2003-12-15 Immunex Corporation Aktiivsete valkude saagise suurendamine
EP1501357A4 (en) 2002-05-06 2009-10-21 Genentech Inc USE OF VEGF FOR THE TREATMENT OF BONE DEFECTS
AU2003251397B2 (en) 2002-06-05 2009-10-01 Genentech, Inc. Compositions and methods for liver growth and liver protection
ZA200504990B (en) 2003-01-09 2006-08-30 Genentech Inc Purification of polypeptides
EP1449848A1 (en) 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Method for the production of cystine-knot proteins
EA200601121A1 (ru) 2003-12-10 2006-10-27 Эли Лилли Энд Компани Мутеины фактора роста фибробластов 21
DE102004015965A1 (de) 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
AU2005257064B2 (en) 2004-06-28 2012-05-10 Yeda Research And Development Co. Ltd. Chimeric proteins and uses thereof
WO2006053568A1 (en) 2004-11-22 2006-05-26 Borean Pharma Aps Tnf antagonists
EP1698637B1 (en) * 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9909326B2 (en) 2010-02-25 2018-03-06 John Clement Preston Scaffolding

Also Published As

Publication number Publication date
US20100261888A1 (en) 2010-10-14
JP5036727B2 (ja) 2012-09-26
JP2009521232A (ja) 2009-06-04
RU2385877C1 (ru) 2010-04-10
EP1973942A2 (en) 2008-10-01
IL191968A (en) 2013-06-27
KR20080087128A (ko) 2008-09-30
NZ568809A (en) 2011-08-26
EP2336164A1 (en) 2011-06-22
AR058625A1 (es) 2008-02-13
WO2007130154A2 (en) 2007-11-15
US20130217867A1 (en) 2013-08-22
IL191968A0 (en) 2008-12-29
EP1973942B1 (en) 2011-02-09
ATE497973T1 (de) 2011-02-15
JP2011254831A (ja) 2011-12-22
TW200734351A (en) 2007-09-16
US20080032343A1 (en) 2008-02-07
HK1119188A1 (en) 2009-07-17
AU2006343279B2 (en) 2012-03-29
DE602007012412D1 (de) 2011-03-24
BRPI0621124A2 (pt) 2011-11-29
MY143274A (en) 2011-04-15
AU2006343279A1 (en) 2007-11-15
KR101067525B1 (ko) 2011-09-27
US8906648B2 (en) 2014-12-09
WO2007130154A3 (en) 2008-06-26
RU2008130072A (ru) 2010-01-27
WO2007130154A8 (en) 2008-04-17
CA2633554C (en) 2012-11-13
CA2633554A1 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
HK1256740A1 (zh) 白介素-13結合蛋白
IL196004A0 (en) Refolding of recombinant proteins
EG26462A (en) Polypeptide production
EP1919956A4 (en) GELING NON-DENATURED PROTEINS WITH POLYSACCHARIDES
ZA200800899B (en) Production of canola protein
HK1123740A1 (zh) 金屬蛋白酶的結合蛋白
IL188671A0 (en) Il-6 binding proteins
HK1119188A1 (en) Recombinant production of heparin binding proteins
ZA200800355B (en) Production of recombinant products using capillary membranes
GB2446550B (en) Methods for production of recombinant alpha1-antitrypsin
GB0426160D0 (en) Production of proteins
IL183106A0 (en) Production of proteins
ZA200805149B (en) Recombinant production of heparin binding proteins
GB0412186D0 (en) Production of recombinant protein
ZA200610190B (en) Heparin binding peptide
TWI347975B (en) Method of producing recombinant protein
GB0511861D0 (en) Proteins
GB0422110D0 (en) Recombinant proteins
GB0422330D0 (en) Protein production
GB0514788D0 (en) Proteins
GB0514481D0 (en) Proteins
GB0513505D0 (en) Proteins
GB0607100D0 (en) Protein production
GB0513653D0 (en) Protein stability